Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.161
+0.009 (5.79%)
At close: Nov 22, 2024, 4:00 PM
0.154
-0.007 (-4.17%)
After-hours: Nov 22, 2024, 6:37 PM EST
Viracta Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 14.12 | 17.32 | 24.33 | 15.44 | 5.35 | 3.19 | |
Research & Development | 33.09 | 33.37 | 26.26 | 23.86 | 13.47 | 8.86 | |
Operating Expenses | 47.21 | 50.69 | 50.59 | 39.3 | 18.82 | 12.06 | |
Operating Income | -47.21 | -50.69 | -50.59 | -39.3 | -18.82 | -12.06 | |
Interest Expense | -3.7 | -3.7 | -0.58 | -0.49 | -0.22 | -1.66 | |
Interest & Investment Income | 3.35 | 3.35 | 1.17 | 0.04 | 0.05 | 0.06 | |
Other Non Operating Income (Expenses) | 4.28 | -0.01 | 0.8 | -0.29 | -0.03 | 0.01 | |
EBT Excluding Unusual Items | -43.29 | -51.06 | -49.2 | -40.04 | -19.02 | -13.64 | |
Gain (Loss) on Sale of Assets | - | - | - | 13.5 | - | - | |
Other Unusual Items | - | - | - | 0.26 | - | 0.08 | |
Pretax Income | -43.29 | -51.06 | -49.2 | -114.76 | -19.02 | -13.56 | |
Net Income | -43.29 | -51.06 | -49.2 | -114.76 | -19.02 | -13.56 | |
Net Income to Common | -43.29 | -51.06 | -49.2 | -114.76 | -19.02 | -13.56 | |
Shares Outstanding (Basic) | 39 | 39 | 38 | 32 | 0 | 2 | |
Shares Outstanding (Diluted) | 39 | 39 | 38 | 32 | 0 | 2 | |
Shares Change (YoY) | 1.99% | 2.21% | 18.58% | 9714.39% | -86.22% | 145.73% | |
EPS (Basic) | -1.10 | -1.32 | -1.30 | -3.60 | -58.56 | -5.75 | |
EPS (Diluted) | -1.10 | -1.32 | -1.30 | -3.60 | -58.56 | -5.75 | |
Free Cash Flow | - | -40.03 | -35.5 | -19.1 | -16.11 | -10.38 | |
Free Cash Flow Per Share | - | -1.04 | -0.94 | -0.60 | -49.61 | -4.41 | |
EBITDA | -46.8 | -50.2 | -50.38 | -39.12 | -18.78 | -12.06 | |
D&A For EBITDA | 0.41 | 0.49 | 0.21 | 0.18 | 0.03 | 0 | |
EBIT | -47.21 | -50.69 | -50.59 | -39.3 | -18.82 | -12.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.